Anthony Fauci: Difference between revisions

Line 18: Line 18:
  |ISBN=978-I51076680-8
  |ISBN=978-I51076680-8
  |accessdate=2021-12-28
  |accessdate=2021-12-28
  }}</ref> from which he allocated funds for two randomized controlled trials to be carried out in Africa. The trials supposedly were to determine if male circumcision was an effective at preventing female to male HIV infection, but were so conducted as to prove what the researchers wanted to prove — that male circumcision prevented HIV infection. NIAID approved of:
  }}</ref> from which he allocated funds for two randomized controlled trials to be carried out in Africa. The trials supposedly were to determine if male circumcision was an effective at preventing female to male HIV infection, but were so conducted as to prove what the researchers wanted to prove — that male circumcision prevented HIV infection. Fauci's NIAID approved of:


* A grant (UO1 AI11171-01-02) from the National Institutes of Allergy and Infectious Disease (NIAID), Division of AIDS, National Institutes of Health (NIH), and in part by the Division of Intramural Research, NIAID, NIH resulted in:   
* A grant (UO1 AI11171-01-02) from the National Institutes of Allergy and Infectious Disease (NIAID), Division of AIDS, National Institutes of Health (NIH), and in part by the Division of Intramural Research, NIAID, NIH resulted in:   
Line 26: Line 26:
2.  Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. ''Lancet''. 2007; 369(9562): 657-666.
2.  Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. ''Lancet''. 2007; 369(9562): 657-666.


==Supporter of PEPFAR==